litlas
Log inCreate account

Gavin P. Dunn

Active 2002–2024

74
Papers
23,855
Citations
53
h-index
73
i10-index

Citations

Citations per year for Gavin P. Dunn1905: 1 citations2003: 25 citations2004: 49 citations2005: 105 citations2006: 154 citations2007: 164 citations2008: 166 citations2009: 143 citations2010: 157 citations2011: 174 citations2012: 171 citations2013: 243 citations2014: 205 citations2015: 229 citations2016: 297 citations2017: 307 citations2018: 317 citations2019: 897 citations2020: 1,046 citations2021: 1,055 citations2022: 914 citations2023: 707 citations2024: 1,093 citations2025: 499 citations2026: 23 citations1906–2002: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,599 citing papers, 30.6% of this breakdownChina: 1,600 citing papers, 13.6% of this breakdownGermany: 619 citing papers, 5.3% of this breakdownUnited Kingdom: 541 citing papers, 4.6% of this breakdownItaly: 537 citing papers, 4.6% of this breakdownFrance: 463 citing papers, 3.9% of this breakdownCanada: 352 citing papers, 3% of this breakdownJapan: 348 citing papers, 2.9% of this breakdownAustralia: 297 citing papers, 2.5% of this breakdownSpain: 261 citing papers, 2.2% of this breakdownNetherlands: 245 citing papers, 2.1% of this breakdownSwitzerland: 234 citing papers, 2% of this breakdown
0%30.6%Other 22.7%

Institutions

Fields

  • Medicine50.6%
  • Immunology and Microbiology25.8%
  • Biochemistry, Genetics and Molecular Biology16.6%
  • Engineering2%
  • Neuroscience1.8%
  • Mathematics1.3%
  • Other1.9%

Topics

  • Cancer Immunotherapy and Biomarkers10.5%
  • Immunotherapy and Immune Responses8.5%
  • Immune Cell Function and Interaction5.8%
  • Immune cells in cancer4.3%
  • Glioma Diagnosis and Treatment4.2%
  • CAR-T cell therapy research3.9%
  • Other62.8%

Coauthors

All papers

Open in search
  1. Cancer immunoediting: from immunosurveillance to tumor escape

    Authors: Gavin P. Dunn, Allen T. Bruce, Hiroaki Ikeda, Lloyd J. Old, Robert D. Schreiber - Nature Immunology 2002 cited by 5,284

  2. The Three Es of Cancer Immunoediting

    Authors: Gavin P. Dunn, Lloyd J. Old, Robert D. Schreiber - Annual Review of Immunology 2004 cited by 3,016

  3. The Immunobiology of Cancer Immunosurveillance and Immunoediting

    Authors: Gavin P. Dunn, Lloyd J. Old, Robert D. Schreiber - Immunity 2004 cited by 2,982

  4. Type I interferon is selectively required by dendritic cells for immune rejection of tumors

    Authors: Mark S. Diamond, Michelle Kinder, Hirokazu Matsushita, Mona Mashayekhi, Gavin P. Dunn, Jessica M. Archambault, Hsiaoju Lee, Cora D. Arthur, J. Michael White, Ulrich Kalinke, Kenneth M. Murphy, Robert D. Schreiber - The Journal of Experimental Medicine 2011 cited by 1,046

  5. T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

    Authors: Karolina Woroniecka, Pakawat Chongsathidkiet, Kristen E. Rhodin, Hanna Kemeny, Cosette Dechant, S. Harrison Farber, Aladine A. Elsamadicy, Xiuyu Cui, Shohei Koyama, Christina Jackson, Landon J. Hansen, Tanner M. Johanns, Luis Sánchez-Pérez, Vidyalakshmi Chandramohan, Yen-Rei A. Yu, Darell D. Bigner, Amber Giles, Patrick Healy, Glenn Dranoff, Kent J. Weinhold, Gavin P. Dunn, Peter E. Fecci - Clinical Cancer Research 2018 cited by 646

  6. Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

    Authors: Ravindra Uppaluri, Katie M. Campbell, Ann Marie Egloff, Paul Zolkind, Zachary L. Skidmore, Brian Nussenbaum, Randal C. Paniello, Jason T. Rich, Ryan S. Jackson, Patrik Pipkorn, Loren S. Michel, Jessica Ley, Peter Oppelt, Gavin P. Dunn, Erica K. Barnell, Nicholas C. Spies, Tianxiang Lin, Tiantian Li, David T. Mulder, Youstina Hanna, Iulia Cirlan, Trevor J. Pugh, Tenny Mudianto, Rachel Riley, Liye Zhou, Vickie Y. Jo, Matthew D. Stachler, Glenn J. Hanna, Jason Kass, Robert I. Haddad, Jonathan D. Schoenfeld, Evisa Gjini, Ana Lako, Wade L. Thorstad, Hiram A. Gay, Mackenzie Daly, Scott J. Rodig, Ian S. Hagemann, Dorina Kallogjeri, Jay F. Piccirillo, Rebecca D. Chernock, Malachi Griffith, Obi L. Griffith, Douglas R. Adkins - Clinical Cancer Research 2020 cited by 365

  7. Comprehensive Analysis of Hypermutation in Human Cancer

    Authors: Brittany Campbell, Nicholas Light, David Fabrizio, Matthew Zatzman, Fabio Fuligni, Richard de Borja, Scott Davidson, Melissa Edwards, Julia A. Elvin, Karl P. Hodel, Walter J. Zahurancik, Zucai Suo, Tatiana Lipman, Katharina Wimmer, Christian P. Kratz, Daniel C. Bowers, Theodore W. Laetsch, Gavin P. Dunn, Tanner M. Johanns, Matthew Grimmer, Ivan Smirnov, Valérie Larouche, David Samuel, Annika Bronsema, Michael Osborn, Duncan Stearns, Pichai Raman, Kristina A. Cole, Phillip B. Storm, Michal Yalon, Enrico Opocher, Gary Mason, Gregory A. Thomas, Magnus Sabel, Ben George, David S. Ziegler, Scott Lindhorst, Vanan Magimairajan Issai, Shlomi Constantini, Helen Toledano, Ronit Elhasid, Roula Farah, Rina Dvir, Peter B. Dirks, Annie Huang, Melissa A. Galati, Jiil Chung, Vijay Ramaswamy, Meredith S. Irwin, Melyssa Aronson, Carol Durno, Michael D. Taylor, Gideon Rechavi, John M. Maris, Éric Bouffet, Cynthia Hawkins, J Costello, M. Stephen Meyn, Zachary F. Pursell, David Malkin, Uri Tabori, Adam Shlien - Cell 2017 cited by 812

  8. Interferons, immunity and cancer immunoediting

    Authors: Gavin P. Dunn, Catherine Koebel, Robert D. Schreiber - Nature reviews. Immunology 2006 cited by 1,615

  9. Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

    Authors: Giacomo Oliveira, Ann Marie Egloff, Alexander B. Afeyan, Jacquelyn O. Wolff, Zexiang Zeng, Rebecca D. Chernock, Liye Zhou, Cameron Messier, Patrick H. Lizotte, Kathleen L. Pfaff, Kari Stromhaug, Livius Penter, Robert I. Haddad, Glenn J. Hanna, Jonathan D. Schoenfeld, Laura A. Goguen, Donald J. Annino, Vickie Y. Jo, Peter Oppelt, Patrik Pipkorn, Ryan S. Jackson, Sidharth V. Puram, Randal C. Paniello, Jason T. Rich, J. C. Webb, José P. Zevallos, Mena Mansour, Jingxin Fu, Gavin P. Dunn, Scott J. Rodig, Jessica Ley, Luc G.T. Morris, Lara Dunn, Cloud P. Paweletz, Dorina Kallogjeri, Jay F. Piccirillo, Douglas R. Adkins, Catherine J. Wu, Ravindra Uppaluri - Science Immunology 2023 cited by 116

  10. A review of glioblastoma immunotherapy

    Authors: Ravi Medikonda, Gavin P. Dunn, Maryam Rahman, Peter E. Fecci, Michael Lim - Journal of Neuro-Oncology 2020 cited by 295

  11. A critical function for type I interferons in cancer immunoediting

    Authors: Gavin P. Dunn, Allen T. Bruce, Kathleen C. F. Sheehan, Vijay Shankaran, Ravindra Uppaluri, Jack D. Bui, Mark S. Diamond, Catherine Koebel, Cora D. Arthur, J. Michael White, Robert D. Schreiber - Nature Immunology 2005 cited by 597

  12. Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement

    Authors: Stephen Bagley, Shawn Kothari, Rifaquat Rahman, Eudocia Q. Lee, Gavin P. Dunn, Evanthia Galanis, Susan M. Chang, Burt Nabors, Manmeet S. Ahluwalia, Roger Stupp, Minesh P. Mehta, David A. Reardon, Stuart A. Grossman, Erik P. Sulman, John H. Sampson, Simon Khagi, Michael Weller, Timothy F. Cloughesy, Patrick Y. Wen, Mustafa Khasraw - Clinical Cancer Research 2021 cited by 164

  13. Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases

    Authors: Timothy J. Kaufmann, Marion Smits, Jerrold L. Boxerman, Raymond Y. Huang, Daniel P. Barboriak, Michael Weller, Caroline Chung, Christina Tsien, Paul D. Brown, Lalitha Shankar, Evanthia Galanis, Elizabeth R. Gerstner, Martin J. van den Bent, Terry C. Burns, Ian F. Parney, Gavin P. Dunn, Priscilla K. Brastianos, Nancy U. Lin, Patrick Y. Wen, Benjamin M. Ellingson - Neuro-Oncology 2020 cited by 259

  14. Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer

    Authors: Kelsy C. Cotto, Yang-Yang Feng, Avinash Ramu, Megan M. Richters, Sharon L. Freshour, Zachary L. Skidmore, Huiming Xia, Joshua F. McMichael, Jason Kunisaki, Katie M. Campbell, Timothy Hung-Po Chen, Emily B. Rozycki, Douglas R. Adkins, Siddhartha Devarakonda, Sumithra Sankararaman, Yiing Lin, William C. Chapman, Christopher A. Maher, Vivek Arora, Gavin P. Dunn, Ravindra Uppaluri, Ramaswamy Govindan, Obi L. Griffith, Malachi Griffith - Nature Communications 2023 cited by 129

  15. Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma

    Authors: Andrea Schmidts, Ambike Aarti Srivastava, Rishab Ramapriyan, Stefanie R. Bailey, Amanda A. Bouffard, Daniel P. Cahill, Bob S. Carter, William T. Curry, Gavin P. Dunn, Matthew J. Frigault, Elizabeth R. Gerstner, Jack Ghannam, Michael C. Kann, Rebecca C. Larson, Mark B. Leick, Brian V. Nahed, Leland G. Richardson, Irene Scarfò, Jing Sun, Hiroaki Wakimoto, Marcela V. Maus, Bryan D. Choi - Neuro-Oncology Advances 2022 cited by 74

  16. Structure and Ubiquitination-Dependent Activation of TANK-Binding Kinase 1

    Authors: Daqi Tu, Zehua Zhu, Alicia Y. Zhou, Cai‐Hong Yun, Kyung‐Eun Lee, Angela V. Toms, Yiqun Li, Gavin P. Dunn, Edmond M. Chan, Tran C. Thai, Shenghong Yang, Scott B. Ficarro, Jarrod A. Marto, Hyesung Jeon, William C. Hahn, David A. Barbie, Michael J. Eck - Cell Reports 2013 cited by 214

  17. Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank

    Authors: Pavlina Chuntova, Frances Chow, Payal Watchmaker, Mildred Galvez, Amy B. Heimberger, Evan W. Newell, Aarón Díaz, Ronald A. DePinho, Ming O. Li, E. John Wherry, Duane A. Mitchell, Masaki Terabe, Derek A. Wainwright, Jay A. Berzofsky, Christel Herold‐Mende, James R. Heath, Michael Lim, Kim Margolin, E. Antonio Chiocca, Noriyuki Kasahara, Benjamin M. Ellingson, Christine E. Brown, Yvonne Chen, Peter E. Fecci, David A. Reardon, Gavin P. Dunn, Linda M. Liau, J Costello, Wolfgang Wick, Timothy F. Cloughesy, William C. Timmer, Patrick Y. Wen, Robert M. Prins, Michael Platten, Hideho Okada - Neuro-Oncology 2020 cited by 93

  18. Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity

    Authors: Mark J. Smyth, Gavin P. Dunn, Robert D. Schreiber - Advances in immunology 2006 cited by 855

  19. ERK1/2 Regulation of CD44 Modulates Oral Cancer Aggressiveness

    Authors: Nancy P. Judd, Ashley E. Winkler, Oihana Murillo, Joshua J. Brotman, Jonathan H. Law, James S. Lewis, Gavin P. Dunn, Jack D. Bui, John B. Sunwoo, Ravindra Uppaluri - Cancer Research 2011 cited by 228

  20. Genomic landscape of high-grade meningiomas

    Authors: Wenya Linda Bi, Noah F. Greenwald, Malak Abedalthagafi, Jeremiah A. Wala, William J. Gibson, Pankaj K. Agarwalla, Peleg Horowitz, Steven E. Schumacher, Ekaterina Esaulova, Yu Mei, Aaron Chevalier, Matthew Ducar, Aaron R. Thorner, Paul Van Hummelen, Anat Stemmer‐Rachamimov, Maksym Artyomov, Ossama Al‐Mefty, Gavin P. Dunn, Sandro Santagata, Ian F. Dunn, Rameen Beroukhim - npj Genomic Medicine 2017 cited by 210

  21. Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA

    Authors: Christopher Pham Pacia, Jinyun Yuan, Yimei Yue, Lu Xu, Arash Nazeri, Rupen Desai, H. Michael Gach, Xiaowei Wang, Michael Talcott, Aadel A. Chaudhuri, Gavin P. Dunn, Eric C. Leuthardt, Hong Chen - Theranostics 2021 cited by 71

  22. Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade

    Authors: Crismita Dmello, Junfei Zhao, Li Chen, Andrew Gould, Brandyn Castro, Víctor A. Arrieta, Daniel Y. Zhang, Kwang-Soo Kim, Deepak Kanojia, Peng Zhang, Jason Miska, Ragini Yeeravalli, Karl J. Habashy, Ruth Saganty, Seong Jae Kang, Jawad Fares, Connor Liu, Gavin P. Dunn, Elizabeth T. Bartom, Matthew J. Schipma, Patrick D. Hsu, Mahmoud S. Alghamri, Maciej S. Lesniak, Amy B. Heimberger, Raúl Rabadán, Catalina Lee-Chang, Adam M. Sonabend - Nature Communications 2023 cited by 46

  23. Single-cell profiling of human dura and meningioma reveals cellular meningeal landscape and insights into meningioma immune response

    Authors: Anthony Z. Wang, Jay A. Bowman-Kirigin, Rupen Desai, Liang‐I Kang, Pujan R. Patel, Bhuvic Patel, Saad M. Khan, Diane Bender, M. Caleb Marlin, Jingxian Liu, Joshua W. Osbun, Eric C. Leuthardt, Michael R. Chicoine, Ralph G. Dacey, Gregory J. Zipfel, Albert H. Kim, David G. DeNardo, Allegra A. Petti, Gavin P. Dunn - Genome Medicine 2022 cited by 113

  24. Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma

    Authors: Tatenda Mahlokozera, Bhuvic Patel, Hao Chen, Patrick DeSouza, Xuan Qu, Diane D. Mao, Daniel Hafez, Wei Yang, Rukayat Taiwo, Mounica Paturu, Afshin Salehi, Amit D. Gujar, Gavin P. Dunn, Nima Mosammaparast, Allegra A. Petti, Hiroko Yano, Albert H. Kim - Nature Communications 2021 cited by 60